China’s drugmakers can’t sell mRNA shots but haven’t quit yet
By Andrew Silver SHANGHAI/SUZHOU, China (Reuters) – China’s vaccine developers
drugmakers
China drugmakers axe IPO plans as they face scrutiny in anti-graft drive
By Jason Xue and Tom Westbrook SHANGHAI (Reuters) – A
Drugmakers set strategy for legal fight against US pricing regulation
By Patrick Wingrove and Michael Erman (Reuters) – Some of
Drugmakers propose swift pandemic response benefiting poorer countries
FRANKFURT – Global drugmakers are lobbying for wealthy nations to
Russia says medicine production stable as drugmakers pull out -RIA
– Russian Health Minister Mikhail Murashko on Thursday said the
U.S. should review drugmakers’ opioid settlement tax breaks – House panel
WASHINGTON – The U.S. Justice and Treasury Departments should review